Antioxidant supplements block the response of HDL to simvastatin-niacin therapy in patients with coronary artery disease and low HDL.
about
Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseasesVitamins C and E: beneficial effects from a mechanistic perspectiveAntioxidants, inflammation and cardiovascular diseaseComplexity of vitamin E metabolismTreatment of metabolic syndromeRelationship between glycemic status and progression of carotid intima-media thickness during treatment with combined statin and extended-release niacin in ARBITER 2Alpha-tocopherol is ineffective in preventing the decomposition of preformed lipid peroxides and may promote the accumulation of toxic aldehydes: a potential explanation for the failure of antioxidants to affect human atherosclerosis.Apolipoprotein L-I is positively associated with hyperglycemia and plasma triglycerides in CAD patients with low HDL.Effect of statins on HDL-C: a complex process unrelated to changes in LDL-C: analysis of the VOYAGER Database.Cholesterol esterification and atherogenic index of plasma correlate with lipoprotein size and findings on coronary angiography.Niacin for primary and secondary prevention of cardiovascular events.An update: vitamin E supplementation and heart disease.Herbal, vitamin, and mineral supplement use in patients enrolled in a cardiac rehabilitation program.Vitamin E and its role in the prevention of atherosclerosis and carcinogenesis: a review.Agents that stabilise atherosclerotic plaque.Antioxidant-induced stress.Differing Relations to Early Atherosclerosis between Vitamin C from Supplements vs. Food in the Los Angeles Atherosclerosis Study: A Prospective Cohort Study.Natural health product interactions with medication.Hypercholesterolemia: its impact on ischemia-reperfusion injury.Should both HDL-C and LDL-C be targets for lipid therapy? A review of current evidence.Mechanisms for the prevention of vitamin E excessVitamins and cardiovascular disease.Trends in dietary supplement use in a cohort of postmenopausal women from IowaNiacin: a re-emerging pharmaceutical for the treatment of dyslipidaemia.Lipoprotein lipase and hepatic lipase: their relationship with HDL subspecies Lp(A-I) and Lp(A-I,A-II).Selenium supplementation in the critically ill.Pharmaconutrition review: physiological mechanisms.The effect of nutritional supplements on serum high-density lipoprotein cholesterol and apolipoprotein A-I.The mythology of antioxidant therapy.Effects of antioxidant vitamins along with atorvastatin and atorvastatin-niacin combination on diet-induced hypercholesterolemia in rats.Statins and modulation of oxidative stress.Simvastatin and vitamin E effects on cardiac and hepatic oxidative stress in rats fed on high fat diet.Impact of simvastatin, niacin, and/or antioxidants on cholesterol metabolism in CAD patients with low HDL.Effect of L-arginine and selenium added to a hypocaloric diet enriched with legumes on cardiovascular disease risk factors in women with central obesity: a randomized, double-blind, placebo-controlled trial.Haplotypes of the cholesteryl ester transfer protein gene predict lipid-modifying response to statin therapy.Vitamin E does not regress hypercholesterolemic atherosclerosis.Effects of combined administration of low dose atorvastatin and vitamin E on inflammatory markers and endothelial function in patients with heart failure.Metabolic response to selenium supplementation in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.Association between HDL Cholesterol Levels and the Consumption of Vitamin A in Metabolically Healthy Obese Lebanese: A Cross-Sectional Study among Adults in Lebanon.
P2860
Q24242944-B5EF2C85-7C76-4E79-9642-670BE336C4C1Q24617202-8AB10445-89A8-40E5-95F8-ED9DBD27B477Q26823009-25FDFF49-8B28-48CE-A23C-0E79FDB21E82Q28068513-2AE41FCC-7FA1-4858-8FC6-B0742503F155Q28168652-7C52F28E-12A0-45EF-A36B-351171B6EEAFQ28217438-8159AD25-6014-4DAB-8765-4A2180ADC779Q33741152-4F9B06A3-85FC-493A-B3B3-E99D5A4131F2Q34377359-CAAB6365-0550-4CCA-913C-03E26B2B79BAQ34559971-A9402479-EA75-44FD-81FC-2A823D70F144Q34560793-6A220303-2ABE-47DF-A798-71F41FBCF289Q34682221-FBE9CD5A-4291-4521-B2E2-67C4A125B848Q34756107-366B8E15-36C4-407C-9F9C-4AAE55BD62B2Q35050124-20D9C03E-0AED-4000-958B-7953A7B97FEDQ35190947-EBB2A1A7-1ED1-49C6-B65E-D117890F2847Q35547296-412071C5-FEAC-4CC0-B2CC-4B9C26704A5AQ35795854-D20A9E9C-C99E-47A1-B41D-19B13B105F11Q36247805-812201D0-B473-4603-8CE6-694C7AC96A9AQ36278312-34002F09-8004-48F5-9525-AC84C3A25775Q36314857-39F5BE2E-BD38-4CE3-9F1B-F0A3EA718EB6Q36422727-48A9ECDB-84F4-40B6-87BD-1C33CA107E62Q37076463-1878EA62-F476-4235-A7B8-370C033297F7Q37282850-001BF19E-B2EE-42BB-BE31-0460530E8A34Q37306034-1794ED4A-47B2-4FF2-8712-84B3475D3898Q37376937-CE421245-1BF7-4782-88D0-EA53A6661078Q37401325-FEA79F5F-3CDF-448A-969B-7E17D66B6C78Q37981599-ABE421B1-35A9-43A3-9058-6CAF99862289Q38134686-D94B3641-2B3D-47B3-BB69-4F585B211FBDQ38194113-AB259E5B-9CFA-4344-93A9-2B21AFDE91ABQ42410318-7972BDFB-D668-40E4-889C-862929B29A11Q42644238-6F6F4309-2118-4D6B-8D3F-57A56AF02A7CQ43215640-4DC8D7C4-E06A-4239-85D7-F5A3EBAAEC23Q44226166-4D791EC0-74A6-4604-8486-15BBB6153849Q44300036-F6301A6C-9AFF-4846-8EF0-F3D339711688Q44528771-FBBE83BA-97DF-4139-92DD-2A71EB2E3231Q44635664-965823CA-659E-4AB3-85B0-395A002041CBQ45982019-CA3E0961-543C-4CE8-BD74-9C21C80BFD8CQ46624363-72AF1D18-CFCE-4707-9067-3E8A13C7EE5FQ51310893-EFB38CB7-C0CF-4854-B663-AB6F497DFBEEQ55508877-BAB9016D-673E-48DF-918B-59577F5F9BFD
P2860
Antioxidant supplements block the response of HDL to simvastatin-niacin therapy in patients with coronary artery disease and low HDL.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Antioxidant supplements block ...... ry artery disease and low HDL.
@en
Antioxidant supplements block ...... ry artery disease and low HDL.
@nl
type
label
Antioxidant supplements block ...... ry artery disease and low HDL.
@en
Antioxidant supplements block ...... ry artery disease and low HDL.
@nl
prefLabel
Antioxidant supplements block ...... ry artery disease and low HDL.
@en
Antioxidant supplements block ...... ry artery disease and low HDL.
@nl
P2093
P356
P1476
Antioxidant supplements block ...... ry artery disease and low HDL.
@en
P2093
P304
P356
10.1161/HQ0801.095151
P407
P577
2001-08-01T00:00:00Z